EU withdraws marketing authorisation for Abbvie's hepatitis C drug

EU withdraws marketing authorisation for Abbvie's hepatitis C drug

Source: 
Reuters
snippet: 

The European Medicines Agency said on Tuesday that it has withdrawn the marketing authorisation for Abbvie's (ABBV.N) hepatitis C drug Exviera at the request of the company.
The regulator said it withdrew the authorisation on Sept. 25. It added that the authorisation holder, AbbVie Deutschland GmbH & Co. KG, had informed the European Commission of its decision to "permanently discontinue the marketing of the product for commercial reasons."